Article

Web site focuses on dry eye

TearLab Corp. has launched the allaboutdryeye.com consumer Web site and social media program to support the company?s accreditation program in North America.

San Diego-TearLab Corp. has launched the allaboutdryeye.com consumer Web site and social media program to support the company’s accreditation program in North America.

The site was designed to give people who have dry eye a place to share their experiences, ask questions, learn about the science behind this condition, connect with doctors and other patients, and locate an accredited treatment center.

Accredited dry eye centers are eye-care practices dedicated to providing high-quality care for the condition using advanced ophthalmic diagnostic techniques and treatments. To become accredited, these centers and their appropriate staff members must complete activities required by the Clinical Laboratory Improvement Amendments, follow best practices for dry eye diagnosis and patient management, participate in Web seminars offered by the company, and complete technician certification training.

“Despite a large and growing patient population, dry eye disease has not historically been a major area of eye-care practice,” said Elias Vamvakas, TearLab’s chief executive officer. “There were a variety of reasons for that, including the limited understanding of the disease; the lack of a simple-to-use, objective, and accurate diagnostic tool; and a limited number of treatment options. As a result, [patients with] dry eye disease were largely left to suffer through the disease on their own.”

With the number of treatment options and potential treatment options increasing, however, “it is the right time to build an online community like allaboutdryeye.com to spread the word on the importance of properly diagnosing and treating dry eye disease,” he added.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.